CY2429B1 - Substituted 3,5-diphenyl-1,2,4-triazoles and theiruse as pharmaceutical metal chelators. - Google Patents
Substituted 3,5-diphenyl-1,2,4-triazoles and theiruse as pharmaceutical metal chelators.Info
- Publication number
- CY2429B1 CY2429B1 CY0400016A CY0400016A CY2429B1 CY 2429 B1 CY2429 B1 CY 2429B1 CY 0400016 A CY0400016 A CY 0400016A CY 0400016 A CY0400016 A CY 0400016A CY 2429 B1 CY2429 B1 CY 2429B1
- Authority
- CY
- Cyprus
- Prior art keywords
- theiruse
- triazoles
- diphenyl
- substituted
- metal chelators
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/04—Chelating agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH159396 | 1996-06-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
CY2429B1 true CY2429B1 (en) | 2004-11-12 |
Family
ID=4214048
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY0400016A CY2429B1 (en) | 1996-06-25 | 2004-02-27 | Substituted 3,5-diphenyl-1,2,4-triazoles and theiruse as pharmaceutical metal chelators. |
CY2007005C CY2007005I2 (el) | 1996-06-25 | 2007-02-09 | Υποκατεστημενες 3,5-διφαινυλ-1,2,4-τριαζολες και η χρηση τους ως φαρμακευτικων χηλικων σκευασματων για μεταλλα |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY2007005C CY2007005I2 (el) | 1996-06-25 | 2007-02-09 | Υποκατεστημενες 3,5-διφαινυλ-1,2,4-τριαζολες και η χρηση τους ως φαρμακευτικων χηλικων σκευασματων για μεταλλα |
Country Status (37)
Country | Link |
---|---|
US (3) | US6465504B1 (ko) |
EP (1) | EP0914118B1 (ko) |
JP (1) | JP3541042B2 (ko) |
KR (1) | KR100616378B1 (ko) |
CN (1) | CN1146415C (ko) |
AP (1) | AP1127A (ko) |
AR (1) | AR007479A1 (ko) |
AT (1) | ATE226435T1 (ko) |
AU (1) | AU718037B2 (ko) |
BG (1) | BG64248B1 (ko) |
BR (1) | BR9709973A (ko) |
CA (1) | CA2255951C (ko) |
CY (2) | CY2429B1 (ko) |
CZ (1) | CZ291470B6 (ko) |
DE (3) | DE122007000020I2 (ko) |
DK (1) | DK0914118T3 (ko) |
ES (1) | ES2187785T3 (ko) |
FR (1) | FR06C0049I2 (ko) |
GE (1) | GEP20084355B (ko) |
HK (1) | HK1020530A1 (ko) |
HU (1) | HU226232B1 (ko) |
IL (1) | IL127212A0 (ko) |
LT (1) | LTC0914118I2 (ko) |
LU (1) | LU91291I2 (ko) |
MY (1) | MY129541A (ko) |
NL (1) | NL300248I2 (ko) |
NO (3) | NO317180B1 (ko) |
NZ (1) | NZ333308A (ko) |
OA (1) | OA10946A (ko) |
PL (1) | PL194758B1 (ko) |
PT (1) | PT914118E (ko) |
RU (1) | RU2208010C2 (ko) |
SI (1) | SI0914118T1 (ko) |
SK (1) | SK284319B6 (ko) |
TR (1) | TR199802693T2 (ko) |
TW (1) | TW533205B (ko) |
WO (1) | WO1997049395A1 (ko) |
Families Citing this family (104)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6677487B2 (en) | 2001-08-30 | 2004-01-13 | Pharmacia Corporation | α-haloenamine reagents |
GB0126618D0 (en) * | 2001-11-06 | 2002-01-02 | Novartis Ag | Organic compounds |
ES2192494B1 (es) * | 2002-03-27 | 2005-02-16 | Consejo Superior De Investigaciones Cientificas | Derivados de 1,2,4-triazol con propiedades cannabinoides. |
US8829198B2 (en) | 2007-10-31 | 2014-09-09 | Proteotech Inc | Compounds, compositions and methods for the treatment of beta-amyloid diseases and synucleinopathies |
GB0223978D0 (en) * | 2002-10-15 | 2002-11-20 | Novartis Ag | Organic compound |
US20050008699A1 (en) * | 2003-07-11 | 2005-01-13 | Fred Wehling | Effervescent glucosamine composition |
AU2004298761A1 (en) * | 2003-12-19 | 2005-06-30 | Novartis Ag | Combination of (a) N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine and (b) at least one hypusination inhibitor and the use thereof |
GB0408078D0 (en) * | 2004-04-08 | 2004-05-12 | Novartis Ag | Organic compounds |
US9737511B2 (en) * | 2004-05-24 | 2017-08-22 | Geoffrey C. GURTNER | Method of treating or preventing pathologic effects of acute increases in hyperglycemia and/or acute increases of free fatty acid flux |
EP1755579A4 (en) * | 2004-05-24 | 2009-06-10 | Univ New York | METHOD FOR TREATING OR PREVENTING PATHOLOGICAL EFFECTS OF AN ACUTE INCREASE OF HYPERGLYCEMIA AND / OR ACUTE INCREASE IN FREE FATTY ACID FLUID |
US20080114001A1 (en) * | 2005-01-28 | 2008-05-15 | Manley Paul W | Use of Pyrimidylaminobenzamides for the Treatment of Diseases that Respond to Modulation of Tie-2 Kinase Activity |
MX2007009591A (es) * | 2005-02-10 | 2007-09-12 | Novartis Ag | Metodos para disposicion mejorada de farmacos. |
KR20080003933A (ko) * | 2005-05-31 | 2008-01-08 | 노파르티스 아게 | 철이 발병에 관여하는 간질환의 치료 |
EP1940360A1 (en) * | 2005-10-19 | 2008-07-09 | Novartis AG | Dispersible tablets comprising deferasirox |
WO2007051773A1 (en) * | 2005-11-01 | 2007-05-10 | Novartis Ag | Method of scintigraphy |
NZ572299A (en) * | 2006-05-09 | 2010-07-30 | Novartis Ag | Combination comprising a substituted 3,5-diphenyl-1,2,4-triazole and a platinum compound and use thereof |
NZ572155A (en) | 2006-05-23 | 2011-11-25 | Novartis Ag | Use of deferasirox for treating iron overload resulting from hereditary haemochromatosis |
CL2007002026A1 (es) | 2006-07-13 | 2008-06-06 | Los Angeles Biomed Res Inst | Composicion que comprende al menos un compuesto quelante de hierro y al menos un agente antifungico; y metodo para el tratamiento o prevencion de una condicion fungica. |
EP2049108A1 (en) * | 2006-08-04 | 2009-04-22 | Novartis AG | Treatment of endocrine dysfunction using iron chelators |
EP1927591A1 (en) * | 2006-11-29 | 2008-06-04 | Novartis AG | Polymorphic Forms of Deferasirox (ICL670) |
MX2009005619A (es) | 2006-11-29 | 2009-06-08 | Novartis Ag | Formas poliformicas del deferasirox (icl670a). |
US20080262060A1 (en) * | 2007-01-29 | 2008-10-23 | Toth Zoltan G | Crystalline forms of Deferasirox |
AU2008250041A1 (en) * | 2007-05-14 | 2008-11-20 | Novartis Ag | Use of iron chelator for the treatment of myocardial infarction |
EP1994930A1 (en) * | 2007-05-22 | 2008-11-26 | Novartis AG | Triazol compounds for treating biofilm formation |
WO2009016359A1 (en) * | 2007-07-27 | 2009-02-05 | Pliva Hrvatska D.O.O. | New forms of deferasirox |
US20090082412A1 (en) * | 2007-09-26 | 2009-03-26 | Protia, Llc | Deuterium-enriched deferasirox |
EP2062572A1 (en) | 2007-11-19 | 2009-05-27 | Teva Pharmaceutical Industries Ltd. | Pharmaceutical compositions |
CZ301873B6 (cs) | 2008-01-30 | 2010-07-14 | Farmak, A. S. | Zpusob prípravy kyseliny 4-[3,5-bis(2-hydroxyfenyl)-[1,2,4]triazol-1-yl]benzoové |
WO2009106824A2 (en) * | 2008-02-25 | 2009-09-03 | Cipla Limited | Pharmaceutical formulations |
WO2009111611A2 (en) | 2008-03-05 | 2009-09-11 | Proteotech Inc. | Compounds, compositions and methods for the treatment of islet amyloid polypeptide (iapp) accumulation in diabetes |
US20110097413A1 (en) * | 2008-04-21 | 2011-04-28 | Actavis Group Ptc Ehf | Solid state forms of deferasirox salts and process for the preparation thereof |
US20110171138A1 (en) * | 2008-06-02 | 2011-07-14 | Actavis Group Ptc Ehf | Substantially pure deferasirox and processes for the preparation thereof |
JPWO2010032489A1 (ja) | 2008-09-22 | 2012-02-09 | 国立大学法人旭川医科大学 | 鉄キレート剤及びその製造方法、並びに鉄イオンの定量・捕捉方法 |
US10098857B2 (en) | 2008-10-10 | 2018-10-16 | The Board Of Trustees Of The Leland Stanford Junior University | Topical and transdermal delivery of HIF-1 modulators to prevent and treat chronic wounds |
WO2010092419A1 (en) | 2009-02-12 | 2010-08-19 | Assistance Publique - Hopitaux De Paris | Combined treatment of multiple sclerosis |
CN102639557A (zh) | 2009-03-19 | 2012-08-15 | 美国加州大学洛杉矶海滨分校医学中心的洛杉矶生物医学研究所 | 用于治疗毛霉菌病和其它真菌性疾病的疫苗组合物和方法 |
IT1398770B1 (it) * | 2009-07-22 | 2013-03-18 | Bellacchio | Oligonucleotidi attivabili mediante l'appaiamento con sequenze di acidi nucleici e loro uso |
WO2011021218A2 (en) * | 2009-08-12 | 2011-02-24 | Msn Laboratories Limited | Process for the preparation of 4-[3,5-bis(2-hydroxyphenyl)-1h-1,2,4-triazol-1-yl]-benzoic acid and its amine salts |
CN102638985A (zh) | 2009-12-07 | 2012-08-15 | Mapi医药公司 | 地拉罗司的制备方法和地拉罗司多晶型物 |
CA2805568A1 (en) | 2010-07-08 | 2012-01-12 | Ratiopharm Gmbh | Oral dosage form of deferasirox |
US8907083B2 (en) * | 2010-08-25 | 2014-12-09 | Ramamohan Rao Davuluri | Process for the preparation, of 2-(2-hydroxyphenyl)-benz [1, 3] oxazin-4-one and its use for preparation of 4-[3, 5-bis (2-hydroxyphenyl)-IH-I, 2, 4-triazolTI-yl] benzoic acid |
AP3578A (en) * | 2010-10-01 | 2016-02-08 | Cipla Ltd | Pharmaceutical composition comprising deferasirox |
US9018389B2 (en) | 2010-11-24 | 2015-04-28 | Alembic Pharmaceuticals, Ltd. | Process for the preparation of Deferasirox |
JP5900968B2 (ja) | 2011-01-14 | 2016-04-06 | 株式会社ダステック | 高分子鉄キレート剤 |
US20140276107A1 (en) | 2011-10-14 | 2014-09-18 | Photocure Asa | Photodynamic diagnosis |
WO2013053904A1 (en) | 2011-10-14 | 2013-04-18 | Photocure Asa | Stent |
US8822464B2 (en) | 2011-11-28 | 2014-09-02 | Boehringer Ingelheim International Gmbh | N-aryl-piperazine derivatives and their use as positive allosteric modulators of mGluR5 receptors |
US8741892B2 (en) | 2011-12-05 | 2014-06-03 | Boehringer Ingelheim International Gmbh | Compounds |
US8642774B2 (en) * | 2011-12-08 | 2014-02-04 | Boehringer Ingelheim International Gmbh | Compounds |
US8846948B2 (en) | 2011-12-13 | 2014-09-30 | Boehringer Ingelheim International Gmbh | Compounds |
US8796467B2 (en) | 2011-12-13 | 2014-08-05 | Boehringer Ingelheim International Gmbh | Compounds |
US8883789B2 (en) | 2011-12-14 | 2014-11-11 | Boehringer Ingelheim International Gmbh | Piperazine derivatives and their use as positive allosteric modulators of mGluR5 receptors |
US8937176B2 (en) | 2011-12-14 | 2015-01-20 | Boehringer Ingelheim International Gmbh | Compounds |
US8716277B2 (en) | 2011-12-14 | 2014-05-06 | Boehringer Ingelheim International Gmbh | Substituted imidazole compounds useful as positive allosteric modulators of mGlu5 receptor activity |
US8889677B2 (en) | 2012-01-17 | 2014-11-18 | Boehringer Ingellheim International GmbH | Substituted triazoles useful as mGlu5 receptor modulators |
ES2650118T3 (es) * | 2013-03-06 | 2018-01-17 | Biocon Limited | Proceso para la preparación de deferasirox |
CU24348B1 (es) * | 2013-03-08 | 2018-05-08 | Novartis Ag | Formulaciones orales de deferasirox |
MX2015015553A (es) * | 2013-05-10 | 2016-06-17 | Cipla Ltd | Composicion farmceutica de dosis baja. |
DE102013217390A1 (de) | 2013-09-02 | 2015-03-05 | Henkel Ag & Co. Kgaa | Wasch- und Reinigungsmittel mit verbesserter Leistung |
CN103454370B (zh) * | 2013-09-11 | 2014-12-24 | 中美华世通生物医药科技(武汉)有限公司 | 一种利用hplc测定原料药中苯肼类化合物残留的方法 |
JOP20200094A1 (ar) | 2014-01-24 | 2017-06-16 | Dana Farber Cancer Inst Inc | جزيئات جسم مضاد لـ pd-1 واستخداماتها |
JOP20200096A1 (ar) | 2014-01-31 | 2017-06-16 | Children’S Medical Center Corp | جزيئات جسم مضاد لـ tim-3 واستخداماتها |
TWI777174B (zh) | 2014-03-14 | 2022-09-11 | 瑞士商諾華公司 | 針對lag-3之抗體分子及其用途 |
PT2946771T (pt) | 2014-05-20 | 2019-06-27 | Sanovel Ilac Sanayi Ve Ticaret As | Formulação de comprimido dispersível em água compreendendo deferasirox |
EP2987482A1 (en) | 2014-08-22 | 2016-02-24 | Santa Farma Ilaç Sanayi A.S. | Soluble and dispersible pharamaceutical deferasirox formulation |
MA41044A (fr) | 2014-10-08 | 2017-08-15 | Novartis Ag | Compositions et procédés d'utilisation pour une réponse immunitaire accrue et traitement contre le cancer |
CN114920840A (zh) | 2014-10-14 | 2022-08-19 | 诺华股份有限公司 | 针对pd-l1的抗体分子及其用途 |
WO2016100882A1 (en) | 2014-12-19 | 2016-06-23 | Novartis Ag | Combination therapies |
KR20160088965A (ko) | 2015-01-16 | 2016-07-27 | 대원제약주식회사 | 데페라시록스를 함유하는 현탁제 |
EP3268035A4 (en) | 2015-03-10 | 2018-10-31 | Aduro Biotech, Inc. | Compositions and methods for activating "stimulator of interferon gene" -dependent signalling |
CN104817538A (zh) * | 2015-03-13 | 2015-08-05 | 东南大学 | 去铁斯诺-他克林金属离子鳌合剂及其药物用途 |
WO2016167729A1 (en) | 2015-04-16 | 2016-10-20 | Öğün Yusuf Toktamiş | Dispersible tablets comprising deferasirox |
EP3095443A1 (en) | 2015-05-21 | 2016-11-23 | Abdi Ibrahim Ilac Sanayi ve Ticaret A.S. | Pharmaceutical composition comprising deferasirox |
WO2016203488A1 (en) * | 2015-06-16 | 2016-12-22 | Havaldar Freddy H | Preparation of novel deferasirox analogues for antimalarial activity |
US20180207273A1 (en) | 2015-07-29 | 2018-07-26 | Novartis Ag | Combination therapies comprising antibody molecules to tim-3 |
EP3317301B1 (en) | 2015-07-29 | 2021-04-07 | Novartis AG | Combination therapies comprising antibody molecules to lag-3 |
US20180222982A1 (en) | 2015-07-29 | 2018-08-09 | Novartis Ag | Combination therapies comprising antibody molecules to pd-1 |
KR101695970B1 (ko) * | 2015-07-31 | 2017-01-13 | 건일제약 주식회사 | 데페라시록스 함유 산제 및 그 제조방법 |
CN106554770B (zh) * | 2015-09-29 | 2018-10-19 | 杭州杜易科技有限公司 | 一种三唑衍生物金属离子荧光探针及其制备方法和应用 |
PE20181496A1 (es) | 2015-10-23 | 2018-09-18 | Vifor Int Ag | Inhibidores de ferroportina novedosos |
BR112018012138A2 (pt) | 2015-12-17 | 2018-12-04 | Novartis Ag | moléculas de anticorpo para pd-1 e usos das mesmas |
EP3429562A1 (en) | 2016-03-17 | 2019-01-23 | Lupin Limited | Compositions of deferasirox |
EP3507367A4 (en) | 2016-07-05 | 2020-03-25 | Aduro BioTech, Inc. | CYCLIC DINUCLEOTID COMPOUNDS WITH INCLUDED NUCLEIC ACIDS AND USES THEREOF |
EP3518904A1 (en) | 2016-09-30 | 2019-08-07 | Synthon B.V. | Pharmaceutical composition comprising deferasirox |
JOP20180036A1 (ar) | 2017-04-18 | 2019-01-30 | Vifor Int Ag | أملاح لمثبطات فروبورتين جديدة |
UY37695A (es) | 2017-04-28 | 2018-11-30 | Novartis Ag | Compuesto dinucleótido cíclico bis 2’-5’-rr-(3’f-a)(3’f-a) y usos del mismo |
CZ2017255A3 (cs) | 2017-05-04 | 2018-11-14 | Zentiva, K.S. | Filmem potažené tablety Deferasiroxu |
WO2018208242A1 (en) | 2017-05-10 | 2018-11-15 | İlko Ilaç Sanayi Ve Ticaret Anonim Şirketi | Formulation of deferasirox tablet for oral suspension composition with better processability |
WO2018237173A1 (en) | 2017-06-22 | 2018-12-27 | Novartis Ag | ANTIBODY MOLECULES DIRECTED AGAINST CD73 AND CORRESPONDING USES |
WO2019055490A1 (en) | 2017-09-14 | 2019-03-21 | The Board Of Trustees Of The Leland Stanford Junior University | PACKAGING OF IRRADIED FABRIC FOR FAT GREETING RETENTION |
EP3489692A1 (de) | 2017-11-28 | 2019-05-29 | Siemens Healthcare Diagnostics Products GmbH | Prothrombinzeit-reagenz enthaltend einen eisenchelator |
TR201722910A2 (tr) | 2017-12-29 | 2019-07-22 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Deferasi̇roks i̇çeren suda dağilabi̇len tablet formülasyonlari |
KR20190110771A (ko) | 2018-03-21 | 2019-10-01 | 주식회사 한국팜비오 | 데페라시록스를 함유하는 소형 분산성 정제 |
CN108727287B (zh) * | 2018-05-10 | 2020-10-27 | 东南大学 | 1,2,4-三唑类化合物及其盐和应用 |
TW202015726A (zh) | 2018-05-30 | 2020-05-01 | 瑞士商諾華公司 | Entpd2抗體、組合療法、及使用該等抗體和組合療法之方法 |
GR1009592B (el) * | 2018-07-03 | 2019-09-11 | Φαρματεν Α.Β.Ε.Ε. | Φαρμακευτικο σκευασμα που περιλαμβανει εναν χηλικο παραγοντα συμπλεκτικο του σιδηρου και μεθοδος για την παρασκευη αυτου |
KR20200113116A (ko) | 2019-03-22 | 2020-10-06 | 주식회사 한국팜비오 | 데페라시록스를 포함하는 필름코팅정제 |
TW202102478A (zh) | 2019-04-01 | 2021-01-16 | 瑞士商威佛(國際)股份有限公司 | 新穎的鐵螯合物 |
CN114502590A (zh) | 2019-09-18 | 2022-05-13 | 诺华股份有限公司 | Entpd2抗体、组合疗法、以及使用这些抗体和组合疗法的方法 |
IT202000000922A1 (it) | 2020-01-20 | 2021-07-20 | Cage Chemicals S R L | Complessi di ferro e relativi sali come agenti di contrasto per MRI |
EP4052698A1 (en) | 2021-03-05 | 2022-09-07 | Sanovel Ilac Sanayi Ve Ticaret A.S. | Film coated tablet comprising deferasirox |
CN114276305B (zh) * | 2021-12-28 | 2023-11-17 | 中山大学 | 一种三取代苯基-1,2,4-三氮唑衍生物及其制备和治疗神经元损伤的应用 |
CN114591254B (zh) * | 2022-03-31 | 2023-10-13 | 中山大学 | 一种3,5-二取代苯基-1,2,4-三氮唑衍生物及其制备方法和应用 |
CN114478410B (zh) * | 2022-03-31 | 2022-11-29 | 中山大学 | 一种二取代苯基-1,2,4-三氮唑衍生物及其制备和应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH84663A4 (ko) | 1963-01-24 | 1964-11-14 | ||
DE2628152C2 (de) | 1976-06-23 | 1985-03-28 | Bayer Ag, 5090 Leverkusen | Fungizide und nematizide Mittel |
US4528196A (en) * | 1981-02-23 | 1985-07-09 | The United States Of America As Represented By The Department Of Health And Human Services | Chelating agents for the treatment of iron overload |
GB8429307D0 (en) | 1984-11-20 | 1984-12-27 | Shell Int Research | Heterocyclic herbicides |
IL84331A0 (en) * | 1987-11-02 | 1988-04-29 | Yissum Res Dev Co | Pyridoxyl hydrazone derivatives and pharmaceutical compositions containing the same |
US5260322A (en) | 1990-10-08 | 1993-11-09 | Merck & Co., Inc. | Angiotension II antagonists in the treatment of hyperuricemia |
DE4320801A1 (de) * | 1993-06-23 | 1995-01-05 | Fahlberg List Pharma Gmbh | 2-Hydroxyphenylsubstituierte 1,2,4-Triazole und 1,2,4-Oxadiazole, ihre Verwendung als pharmazeutische Wirkstoffe und sie enthaltende Arzneimittel |
-
1997
- 1997-06-23 TW TW086108750A patent/TW533205B/zh not_active IP Right Cessation
- 1997-06-23 MY MYPI97002822A patent/MY129541A/en unknown
- 1997-06-24 JP JP50234898A patent/JP3541042B2/ja not_active Expired - Lifetime
- 1997-06-24 WO PCT/EP1997/003315 patent/WO1997049395A1/en active IP Right Grant
- 1997-06-24 DE DE122007000020C patent/DE122007000020I2/de active Active
- 1997-06-24 AP APAP/P/1998/001407A patent/AP1127A/en active
- 1997-06-24 BR BR9709973A patent/BR9709973A/pt not_active IP Right Cessation
- 1997-06-24 PL PL330119A patent/PL194758B1/pl unknown
- 1997-06-24 CA CA002255951A patent/CA2255951C/en not_active Expired - Lifetime
- 1997-06-24 CN CNB971958319A patent/CN1146415C/zh not_active Expired - Lifetime
- 1997-06-24 TR TR1998/02693T patent/TR199802693T2/xx unknown
- 1997-06-24 DE DE1997616602 patent/DE122007000020I1/de active Pending
- 1997-06-24 CZ CZ19984272A patent/CZ291470B6/cs not_active IP Right Cessation
- 1997-06-24 SK SK1785-98A patent/SK284319B6/sk active Protection Beyond IP Right Term
- 1997-06-24 DK DK97928269T patent/DK0914118T3/da active
- 1997-06-24 NZ NZ333308A patent/NZ333308A/xx not_active IP Right Cessation
- 1997-06-24 EP EP97928269A patent/EP0914118B1/en not_active Expired - Lifetime
- 1997-06-24 ES ES97928269T patent/ES2187785T3/es not_active Expired - Lifetime
- 1997-06-24 KR KR1020057017800A patent/KR100616378B1/ko not_active IP Right Cessation
- 1997-06-24 IL IL12721297A patent/IL127212A0/xx active Protection Beyond IP Right Term
- 1997-06-24 HU HU9903111A patent/HU226232B1/hu active Protection Beyond IP Right Term
- 1997-06-24 AT AT97928269T patent/ATE226435T1/de active
- 1997-06-24 PT PT97928269T patent/PT914118E/pt unknown
- 1997-06-24 RU RU99101050/04A patent/RU2208010C2/ru active Protection Beyond IP Right Term
- 1997-06-24 DE DE69716602T patent/DE69716602T2/de not_active Expired - Lifetime
- 1997-06-24 SI SI9730462T patent/SI0914118T1/xx unknown
- 1997-06-24 AU AU32629/97A patent/AU718037B2/en not_active Expired
- 1997-06-25 AR ARP970102792A patent/AR007479A1/es active IP Right Grant
-
1998
- 1998-12-08 BG BG103003A patent/BG64248B1/bg unknown
- 1998-12-21 NO NO19986024A patent/NO317180B1/no not_active IP Right Cessation
- 1998-12-24 OA OA9800247A patent/OA10946A/en unknown
-
1999
- 1999-11-09 HK HK99105147A patent/HK1020530A1/xx not_active IP Right Cessation
-
2000
- 2000-10-30 US US09/699,765 patent/US6465504B1/en not_active Expired - Lifetime
-
2002
- 2002-09-23 US US10/252,899 patent/US6596750B2/en not_active Expired - Lifetime
-
2003
- 2003-05-29 US US10/447,922 patent/US6723742B2/en not_active Expired - Lifetime
-
2004
- 2004-02-27 CY CY0400016A patent/CY2429B1/xx unknown
-
2006
- 2006-11-27 NL NL300248C patent/NL300248I2/nl unknown
- 2006-11-29 LU LU91291C patent/LU91291I2/fr unknown
- 2006-11-30 NO NO2006017C patent/NO2006017I2/no unknown
- 2006-12-26 FR FR06C0049C patent/FR06C0049I2/fr active Active
-
2007
- 2007-01-16 LT LTPA2007001C patent/LTC0914118I2/lt unknown
- 2007-02-09 CY CY2007005C patent/CY2007005I2/el unknown
- 2007-09-14 GE GEAP200710266A patent/GEP20084355B/en unknown
-
2018
- 2018-04-17 NO NO2018014C patent/NO2018014I2/no unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY2429B1 (en) | Substituted 3,5-diphenyl-1,2,4-triazoles and theiruse as pharmaceutical metal chelators. | |
HK1018780A1 (en) | 6-Phenylpyridine-2-ylamine derivatives, the composition and use thereof. | |
AU4073997A (en) | 1,4-heterocyclic metallprotease inhibitors | |
ZA98362B (en) | 3-heterocyclyl-substituted benzoyl derivatives. | |
AU3770697A (en) | 2- and 2,5-substituted phenylketoenols | |
ZA977687B (en) | Substituted 6,5-hetero-bicyclic derivatives | |
IL128049A0 (en) | Substituted 6,6-hetero-bicyclic derivatives | |
NZ329176A (en) | 2,5-dioxo-imidazolidine derivatives and medicaments | |
IL113402A0 (en) | 3,5 - disubstituted tetrahydrofuran -2- ones | |
PL348668A1 (en) | 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives | |
ZA971883B (en) | 1,3,5-trisubstituted indazole derivatives. | |
ZA962753B (en) | 1,3-Dihydro-2H-imidazol-2-one derivatives. | |
ZA979642B (en) | Heterocyclic compounds, compositions and uses. | |
ZA979643B (en) | Heterocyclic compounds, compositions and uses. | |
ZA979644B (en) | Heterocyclic compounds, compositions and uses. | |
ZA979649B (en) | Heterocyclic compounds, compositions and uses. | |
EP0671452A3 (de) | Rauchgasarme, temperaturbeständige Binde- und Beschichtungsmittel und deren Verwendung. | |
ZA965465B (en) | 2,4,5-Trisubstituted phenylketoenois | |
ZA972302B (en) | 1,25-Dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives. | |
ZA979646B (en) | Heterocyclic compounds, compositions and uses. | |
HK1051123A1 (en) | Fungicidal and insectidical composition. | |
ZA979648B (en) | Heterocyclic compounds, compositions and uses. | |
IL132162A (en) | 2,3-epoxypropionamide derivatives | |
SI1140835T1 (en) | 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives | |
ZA9610708B (en) | Oxaindene derivatives and process for the preparation thereof. |